This is BrainsWay’s global website. The website includes information on clinical indications that were not cleared by the FDA and are considered investigational by the U.S. medical device regulations. BrainsWay D treatment is FDA cleared for patients with MDD who failed to respond to one or more anti-depressants in the current episode.
Walter Reed National Military Medical Center Acquires
a Brainsway® Deep TMS System to Enhance its Treatment of Depression
HACKENSACK, N.J., June 22, 2017 – Brainsway® USA Inc., a subsidiary of Brainsway Ltd. (TASE:BRIN), a leader in the advanced non-invasive treatment of brain disorders, today announced that Walter Reed National Military Medical Center in Bethesda, Maryland acquired a Brainsway Deep Transcranial Magnetic Stimulation (Deep TMS) system. Walter Reed is a world-renown military medical center with a reputation of providing the very highest standards of care to the men, women and families of the U.S. armed forces.
As the flagship center of the U.S. military’s health system, Walter Reed’s mission is to provide innovative, patient-centered healthcare. Walter Reed continues to demonstrate the importance of utilizing cutting-edge technology to improve patient outcomes and continues its commitment to advancing mental health treatment within the military community. Deep TMS will be able to support Walter Reed’s mission by providing advanced care to patients suffering from depression.
“Brainsway is honored that Deep TMS was selected by Walter Reed to expand its mental health treatment program and looks forward to positively impacting the lives of the courageous men and women who have served their country with distinction,” said Aron Tendler M.D., chief medical officer of Brainsway.
“Brainsway’s partnership with Walter Reed will expand access to Deep TMS for patients who are seeking a non-invasive and non-drug treatment option for depression,” said Yaacov Michlin, CEO of Brainsway. “Brainsway fully intends to develop this site as a center of excellence among its growing list of treatment centers across the United States.”